FDA label
What is Nurtec ODT used for?
Nurtec ODT contains rimegepant. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label for Nurtec ODT lists 2 uses: Acute Treatment of Migraine; Preventive Treatment of Episodic Migraine.
Run it in Rivvi
Which 2027 plans near you dropped or restricted Nurtec ODT?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Nurtec ODT, tablet, orally disintegrating
Indications and Usage, quoted from the label by Pfizer Laboratories Div Pfizer Inc (NDA212728). Cross-references to other label sections are left out.
Acute Treatment of Migraine
NURTEC ODT is indicated for the acute treatment of migraine with or without aura in adults.
Preventive Treatment of Episodic Migraine
NURTEC ODT is indicated for the preventive treatment of episodic migraine in adults.
Source: DailyMed label, set id 9ef08e09-1098-35cc-e053-2a95a90a3e1d, version 32, effective June 4, 2026. NDC 72618-3000, one of 3 listings for this product.
Questions
What is Nurtec ODT used for?
The FDA label for Nurtec ODT lists 2 uses: Acute Treatment of Migraine; Preventive Treatment of Episodic Migraine.
What drug class is Nurtec ODT?
FDA lists rimegepant in the Calcitonin Gene-related Peptide Receptor Antagonist established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.
More on Nurtec ODT
- Is Nurtec ODT a controlled substance?Federal schedule
- Generic for Nurtec ODTFDA Orange Book
- Calcitonin Gene-related Peptide Receptor Antagonists listFDA drug class
- Nurtec ODT Medicare Part D coverageBy plan and state
- NDC 72618-3000Nurtec ODT NDC record
- NDC 72618-3001Nurtec ODT NDC record
- NDC 85766-096Nurtec ODT NDC record